Literature DB >> 22608296

Blood basophils from cystic fibrosis patients with allergic bronchopulmonary aspergillosis are primed and hyper-responsive to stimulation by aspergillus allergens.

Yael Gernez1, Colleen E Dunn, Cassie Everson, Erin Mitsunaga, Lakshmi Gudiputi, Karolina Krasinska, Zoe A Davies, Leonore A Herzenberg, Rabindra Tirouvanziam, Richard B Moss.   

Abstract

INTRODUCTION: Fifteen to sixty percent of cystic fibrosis patients harbor Aspergillus fumigatus (Af) in their airways (CF-AC) and some will develop allergic bronchopulmonary aspergillosis (CF-ABPA). Since basophils play a key role in allergy, we hypothesized that they would display alterations in CF-ABPA patients compared to CF-AC or patients without Af colonization (CF).
METHODS: Using flow cytometry, we measured CD203c, CD63 and CD123 levels on basophils from CF-ABPA (N=11), CF-AC (N=14), and CF (N=12) patients before and after ex vivo stimulation with Af allergens.
RESULTS: Baseline CD203c was increased in basophils from CF-ABPA compared to CF-AC and CF patients. Af extract and recombinant Aspf1 stimulated basophils from CF-ABPA patients to markedly upregulate CD203c, along with modest upregulation of CD63 and a CD123 downward trend. Plasma TARC/CCL17 at baseline and post-stimulation cell supernatant histamine levels were similar in the three groups.
CONCLUSIONS: In CF-ABPA, blood basophils are primed and hyperresponsive to Af allergen stimulation.
Copyright © 2012 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22608296     DOI: 10.1016/j.jcf.2012.04.008

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  12 in total

Review 1.  Fungal Pathogens in CF Airways: Leave or Treat?

Authors:  A Singh; A Ralhan; C Schwarz; D Hartl; A Hector
Journal:  Mycopathologia       Date:  2017-08-02       Impact factor: 2.574

2.  Dynamic quantification of antigen molecules with flow cytometry.

Authors:  A E Moskalensky; A V Chernyshev; M A Yurkin; V M Nekrasov; A A Polshchitsin; D R Parks; W A Moore; A Filatenkov; V P Maltsev; D Y Orlova
Journal:  J Immunol Methods       Date:  2015-02-14       Impact factor: 2.303

Review 3.  Progress and challenges in fungal lung disease in cystic fibrosis.

Authors:  Gina Hong
Journal:  Curr Opin Pulm Med       Date:  2022-09-19       Impact factor: 2.868

Review 4.  Aspergillus Species in Bronchiectasis: Challenges in the Cystic Fibrosis and Non-cystic Fibrosis Airways.

Authors:  Sanjay H Chotirmall; Maria Teresa Martin-Gomez
Journal:  Mycopathologia       Date:  2017-05-17       Impact factor: 2.574

Review 5.  Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi.

Authors:  James F Chmiel; Timothy R Aksamit; Sanjay H Chotirmall; Elliott C Dasenbrook; J Stuart Elborn; John J LiPuma; Sarath C Ranganathan; Valerie J Waters; Felix A Ratjen
Journal:  Ann Am Thorac Soc       Date:  2014-10

6.  Earth Mover's Distance (EMD): A True Metric for Comparing Biomarker Expression Levels in Cell Populations.

Authors:  Darya Y Orlova; Noah Zimmerman; Stephen Meehan; Connor Meehan; Jeffrey Waters; Eliver E B Ghosn; Alexander Filatenkov; Gleb A Kolyagin; Yael Gernez; Shanel Tsuda; Wayne Moore; Richard B Moss; Leonore A Herzenberg; Guenther Walther
Journal:  PLoS One       Date:  2016-03-23       Impact factor: 3.240

Review 7.  Animal Models of Cystic Fibrosis Pathology: Phenotypic Parallels and Divergences.

Authors:  Gillian M Lavelle; Michelle M White; Niall Browne; Noel G McElvaney; Emer P Reeves
Journal:  Biomed Res Int       Date:  2016-06-01       Impact factor: 3.411

8.  QFMatch: multidimensional flow and mass cytometry samples alignment.

Authors:  Darya Y Orlova; Stephen Meehan; David Parks; Wayne A Moore; Connor Meehan; Qian Zhao; Eliver E B Ghosn; Leonore A Herzenberg; Guenther Walther
Journal:  Sci Rep       Date:  2018-02-19       Impact factor: 4.379

Review 9.  Allergic Bronchopulmonary Aspergillosis.

Authors:  Michael C Tracy; Caroline U A Okorie; Elizabeth A Foley; Richard B Moss
Journal:  J Fungi (Basel)       Date:  2016-06-06

Review 10.  Immunomodulation in Cystic Fibrosis: Why and How?

Authors:  Vincent D Giacalone; Brian S Dobosh; Amit Gaggar; Rabindra Tirouvanziam; Camilla Margaroli
Journal:  Int J Mol Sci       Date:  2020-05-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.